| Rohit Marwaha, MD | |
|
1925 Pacific Ave, Atlantic City, NJ 08401-6713 | |
| (609) 441-8146 | |
| Not Available |
| Full Name | Rohit Marwaha |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 1925 Pacific Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528364833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA09346100 (New Jersey) | Secondary |
| 208M00000X | Hospitalist | 25MA09346100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlanticare Regional Medical Center | Atlantic city, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlanticare Physician Group Pa | 8527953660 | 495 |
News Archive
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
SEEK, a leading UK privately-owned drug-discovery group, today presented data on the successful conclusion of a Phase I safety and tolerability study for its investigational Universal Influenza Vaccine, FLU-v, at the World Influenza Congress in Amsterdam (7-9 December).
Defense Secretary Robert Gate spoke about the need to control soaring defense costs, especially health care expenses, while Veterans Affairs Secretary Eric Shinseki responded to several health care challenges facing veterans' health care.
A promising but expensive device to prop open blocked arteries in the brain in the hope of preventing disabling or fatal strokes failed in a rigorous study, researchers reported on Wednesday. Those who got the device actually had so many more strokes than those assigned to control risk factors, like blood pressure, cholesterol and diabetes, that the study was abruptly terminated.
Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.
› Verified 2 days ago
| Entity Name | Atlanticare Physician Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093829608 PECOS PAC ID: 8527953660 Enrollment ID: O20040218000405 |
News Archive
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
SEEK, a leading UK privately-owned drug-discovery group, today presented data on the successful conclusion of a Phase I safety and tolerability study for its investigational Universal Influenza Vaccine, FLU-v, at the World Influenza Congress in Amsterdam (7-9 December).
Defense Secretary Robert Gate spoke about the need to control soaring defense costs, especially health care expenses, while Veterans Affairs Secretary Eric Shinseki responded to several health care challenges facing veterans' health care.
A promising but expensive device to prop open blocked arteries in the brain in the hope of preventing disabling or fatal strokes failed in a rigorous study, researchers reported on Wednesday. Those who got the device actually had so many more strokes than those assigned to control risk factors, like blood pressure, cholesterol and diabetes, that the study was abruptly terminated.
Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rohit Marwaha, MD 1925 Pacific Ave, Atlantic City, NJ 08401-6713 Ph: (609) 441-8146 | Rohit Marwaha, MD 1925 Pacific Ave, Atlantic City, NJ 08401-6713 Ph: (609) 441-8146 |
News Archive
At the American Chemical Society (ACS)Spring 2012 National Meeting & Expo (Booth #218), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing new chemistry-focused informatics solutions and technologies, including the Reaction Genius software platform for better chemistry knowledge sharing and workflow productivity.
SEEK, a leading UK privately-owned drug-discovery group, today presented data on the successful conclusion of a Phase I safety and tolerability study for its investigational Universal Influenza Vaccine, FLU-v, at the World Influenza Congress in Amsterdam (7-9 December).
Defense Secretary Robert Gate spoke about the need to control soaring defense costs, especially health care expenses, while Veterans Affairs Secretary Eric Shinseki responded to several health care challenges facing veterans' health care.
A promising but expensive device to prop open blocked arteries in the brain in the hope of preventing disabling or fatal strokes failed in a rigorous study, researchers reported on Wednesday. Those who got the device actually had so many more strokes than those assigned to control risk factors, like blood pressure, cholesterol and diabetes, that the study was abruptly terminated.
Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.
› Verified 2 days ago
Newaz Mohammed Hossain, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 Fax: 609-441-8002 | |
Shahzad Zia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-345-4000 | |
Mohamed Mokhtar Bakr, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-569-1000 | |
Dr. Mohammad H Zaman, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 Fax: 609-441-8002 | |
Jordan Silver, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 | |
Syed Jaleel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-345-4000 | |
Vikram Lal, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-441-8146 Fax: 609-441-8002 |